The personalisation lottery – Lack of accessible regulated testing services is putting patients and health budgets at risk
Health systems and insurances take decisions on reimbursing targeted medicines, doctors focus increasingly on tailoring treatments to individual patients and the molecular biology of their disease. But the need for funded quality-controlled services to do [more]
